Which of the following statements regarding the diagnosis of Metabolic Dysfunction-Associated Steatohepatitis is correct?
October 18, 2024A 54-year-old man with a BMI of 28.5 kg/m2, impaired glucose tolerance, HDL Cholesterol 35 mg/dL 0.905 mmol/L) and arterial hypertension, consuming 3 beers per week, has elevated transaminases and undergoes additional exams
June 28, 2024A man of 40 years of age is diagnosed with slightly elevated transaminases
April 5, 2024In alcohol-related liver cirrhosis
January 26, 2024A man of 32 years with a history of type 1 diabetes and vitiligo is referred by his GP
December 8, 2023The nomenclature for Non-Alcoholic Fatty Liver Disease had recently been changed, based on a long consensus process and has been endorsed by EASL, AASLD and ALEH and a long list of other societies
September 15, 2023A quarter of the global adult population is estimated to have non-alcoholic fatty liver disease (NAFLD)
May 26, 2023Non-alcoholic fatty liver disease (NAFLD) is characterised by excessive hepatic fat accumulation
December 2, 2022Epidemiological evidence suggests a tight relationship between unhealthy lifestyle and non-alcoholic fatty liver disease (NAFLD).
November 18, 2022A 51-year-old woman presents with a Body Mass Index (BMI) < 30 kg/m2
May 6, 2022A 40-year-old man presents with severe alcohol use disorder (AUD), admitting to heavy episodic drinking as well as binge drinking.
May 7, 2021Fibrosis is the most important prognostic factor in NAFLD, correlating with liver-related outcomes and mortality.
Fibrosis is the most important prognostic factor in NAFLD, correlating with liver-related outcomes and mortality. For this reason, the presence of advanced fibrosis is of paramount importance during investigations for NAFLD.September 11, 2020A 50-year old man presents with bilateral parotid gland hypertrophy
How would you screen for harmful alcohol consumption?June 19, 2020
©2019 - EASL. All Rights Reserved. Powered by Enovation.